S203 Introduction: The incidence of the potentially life-threatening "cannot intubate, cannot ventilate" situation is approximately 1/10.000 anesthetics [1]. Percutaneous transtracheal jet ventilation (TTJV) is a widely accepted, effective treatment to restore adequate arterial oxygenation. Unfortunately, the equipment required for "conventional" TTJV is often not immediately available in emergency situations and demands regular maintenance. These systems bear a high risk of barotrauma in cases of treating emergency respiratory distress and complete upper airway obstruction. Alternative, mostly self-assembled transtracheal systems (e.g. oxygen insufflation by squeezing a bag connected to a transtracheal needle (or iv-catheter) by a cutted barrel of a 2-ml-syringe and a tubus connector [2]) fail to achieve effective oxygenation albeit with a lower risk for barotrauma. A new device ("flow-modulator") is introduced allowing oxygenation and drug administration into the patient's lungs by manually controlled, jet-ventilation-like, pulsed gas flow. Methods: The device [3] consists of a short, non-compliant tube (1) with several openings (2) located at opposite sites in front of a syringe connector (3). The device is connected between a transtracheal needle (or iv-catheter) and an oxygen supply delivering oxygen at a rate of at least 15 liters/minute. Intermittent closing and releasing leads to a jet-ventilation-like, pulsed flow. The ratio of the transtracheal needle's (or iv-catheter's) cross-section and the total cross-section of the non-closed openings of the device determines the effective gas flow to the patient (e.g. with a ratio of 1 to 3, 25% of the total gas flow reaches the patient's lungs). Successive closing of openings with equal diameters induces an exponential gas flow increase to the patient's lungs, whereas a linear gas flow profile is achievable with different (decreasing) diameters. Besides, effective jet-nebulizing by injecting a liquid drug through the syringe connector is possible. Currently, the efficacy of the device is examined in an animal model approved by the Institutional Animal Investigation Committee. (Figure 1)Figure 1Results: The closure of all openings and subsequent high gas flow to the patient is only achievable by an intentional digital maneuver. Total release of the openings ensures prompt, quantitative gas discharge to the atmosphere thus minimizing the risk of barotrauma even in case of upper airway obstruction. The construction of the device is characterized by the absence of any mechanical parts. Maintenance is not required. This includes a maximum of system-immanent safety. Malfunction is excluded - a barotrauma can only occur following a physician's fault. First data suggest sufficient oxygenation with concomitant moderate hypercapnia and respiratory acidosis. In no case barotrauma or severe hemodynamic deterioration were observed. Discussion: The device ("flow-modulator") allows safe, variable, manually controlled oxygen-flow into the patient's lungs assuring sufficient oxygenation with moderately impaired ventilation. In addition, drugs (e.g. epinephrine) can be nebulized, reaching even more peripheral tracheobronchial areas. This small device, easy to understand and safely to handle, may become a beneficial tool in the management of the difficult airway - since it fits the smallest pocket even "on the road".